Open-label Study of TAK-875
3 other identifiers
interventional
333
1 country
31
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of treatment with TAK-875 in diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 diabetes-mellitus
Started Jan 2012
Shorter than P25 for phase_3 diabetes-mellitus
31 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2011
CompletedFirst Posted
Study publicly available on registry
September 14, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMarch 22, 2013
March 1, 2013
11 months
September 12, 2011
March 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse events
Study Arms (2)
TAK-875 25 mg
EXPERIMENTALTAK-875 50 mg
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- The participant is an outpatient.
- The participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
You may not qualify if:
- The participant has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease.
- The participant is considered ineligible for the study for any other reason by the investigator or sub-investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Takedalead
Study Sites (31)
Unknown Facility
Katori-shi, Chiba, Japan
Unknown Facility
Niihama-shi, Ehime, Japan
Unknown Facility
Chikushino-shi, Fukuoka, Japan
Unknown Facility
Fukuoka, Fukuoka, Japan
Unknown Facility
Onga-gun, Fukuoka, Japan
Unknown Facility
Yukuhashi-shi, Fukuoka, Japan
Unknown Facility
Hiroshima, Hiroshima, Japan
Unknown Facility
Chitose-shi, Hokkaido, Japan
Unknown Facility
Sapporo, Hokkaido, Japan
Unknown Facility
Koga-shi, Ibaragi, Japan
Unknown Facility
Ushiku-shi, Ibaragi, Japan
Unknown Facility
Chigasaki-shi, Kanagawa, Japan
Unknown Facility
Kamakura-shi, Kanagawa, Japan
Unknown Facility
Minamata-shi, Kumamoto, Japan
Unknown Facility
Yatsushiro-shi, Kumamoto, Japan
Unknown Facility
Sasebo-shi, Nagasaki, Japan
Unknown Facility
Kashihara-shi, Nara, Japan
Unknown Facility
Okinawa-shi, Okinawa, Japan
Unknown Facility
Izumi-shi, Osaka, Japan
Unknown Facility
Suita-shi, Osaka, Japan
Unknown Facility
Fujimi-shi, Saitama, Japan
Unknown Facility
Shimotsuga-gun, Tochigi, Japan
Unknown Facility
Komatsushima-shi, Tokushima, Japan
Unknown Facility
Bunkyo-ku, Tokyo, Japan
Unknown Facility
Chiyoda-ku, Tokyo, Japan
Unknown Facility
Mitaka-shi, Tokyo, Japan
Unknown Facility
Shibuya-ku, Tokyo, Japan
Unknown Facility
Shinjuku-ku, Tokyo, Japan
Unknown Facility
Toshima-ku, Tokyo, Japan
Unknown Facility
Shunan-shi, Yamaguchi, Japan
Unknown Facility
Ube-shi, Yamaguchi, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2011
First Posted
September 14, 2011
Study Start
January 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
March 22, 2013
Record last verified: 2013-03